Current multidisciplinary oncology series

Por Sebio, Ana, Lenz, Heinz-Josef
Publicado em 2014

Molecular Pathways: Hippo Signaling, a Critical Tumor Suppressor

Por Sebio, Ana, Lenz, Heinz-Josef
Publicado no Clin Cancer Res (2015)

Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs

Por Nogales, Vanesa, Reinhold, William C., Varma, Sudhir, Martinez-Cardus, Anna, Moutinho, Catia, Moran, Sebastian, Heyn, Holger, Sebio, Ana, Barnadas, Agusti, Pommier, Yves, Esteller, Manel
Publicado no Oncotarget (2015)

Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stage II/III colon cancer

Por Sebio, Ana, Matsusaka, Satoshi, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stremitzer, Stefan, Stintzing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado no Pharmacogenomics J (2015)

Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer

Por Sebio, Ana, Gerger, Armin, Matsusaka, Satoshi, Yang, Dongyun, Zhang, Wu, Stremitzer, Stefan, Stintizing, Sebastian, Sunakawa, Yu, Yamauchi, Shinichi, Ning, Yan, Fujimoto, Yoshiya, Ueno, Masashi, Lenz, Heinz-Josef
Publicado no Pharmacogenet Genomics (2015)

Genetic variations in angiopoietin and pericyte pathways and clinical outcome in patients with resected colorectal liver metastases

Por Stremitzer, Stefan, Zhang, Wu, Yang, Dongyun, Ning, Yan, Stintzing, Sebastian, Sebio, Ana, Sunakawa, Yu, Yamauchi, Shinichi, Matsusaka, Satoshi, El-Khoueiry, Rita, Stift, Judith, Wrba, Friedrich, Gruenberger, Thomas, Lenz, Heinz-Josef
Publicado no Cancer (2015)

TWIST1 polymorphisms predict survival in patients with metastatic colorectal cancer receiving first-line bevacizumab plus oxaliplatin-based chemotherapy

Por Matsusaka, Satoshi, Zhang, Wu, Cao, Shu, Hanna, Diana L., Sunakawa, Yu, Sebio, Ana, Ueno, Masashi, Yang, Dongyun, Ning, Yan, Parekh, Anish, Okazaki, Satoshi, Berger, Martin D., Ichikawa, Wataru, Mizunuma, Nobuyuki, Lenz, Heinz-Josef.
Publicado no Mol Cancer Ther (2016)

Prognostic impact of c-MET polymorphism on clinical outcome in loco-regional gastric cancer patients

Por Sunakawa, Yu, Wakatsuki, Takeru, Yang, Dongyun, Zhang, Wu, Ning, Yan, Stintzing, Sebastian, Stremitzer, Stefan, Yamauchi, Shinichi, Sebio, Ana, El-khoueiry, Rita, Iqbal, Syma, Afsaneh, Barzi, Gerger, Armin, Stotz, Michael, Azuma, Mizutomo, Watanabe, Masahiko, Koizumi, Wasaburo, Lenz, Heinz-Josef
Publicado no Pharmacogenet Genomics (2014)

Polymorphisms in genes involved in EGFR-turnover are predictive for cetuximab efficacy in colorectal cancer

Por Stintzing, Sebastian, Zhang, Wu, Heinemann, Volker, Neureiter, Daniel, Kemmerling, Ralf, Kirchner, Thomas, Jung, Andreas, Folwaczny, Matthias, Yang, Dongyun, Ning, Yan, Sebio, Ana, Stremitzer, Stefan, Sunakawa, Yu, Matsusaka, Satoshi, Yamauchi, Shinichi, Loupakis, Fotios, Cremolini, Chiara, Falcone, Alfredo, Lenz, Heinz-Josef
Publicado no Mol Cancer Ther (2015)